Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001789769-23-000049
Filing Date
2023-04-24
Accepted
2023-04-24 16:31:43
Documents
5

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14aproxyadditional2023.htm DEFA14A 10482
2 GRAPHIC notice1a.jpg GRAPHIC 91106
3 GRAPHIC notice2a.jpg GRAPHIC 120680
4 GRAPHIC notice3a.jpg GRAPHIC 170905
5 GRAPHIC notice4a.jpg GRAPHIC 31955
  Complete submission text file 0001789769-23-000049.txt   582910
Mailing Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219
Business Address 3963 MAPLE AVENUE SUITE 350 DALLAS TX 75219 (972) 499-3350
Instil Bio, Inc. (Filer) CIK: 0001789769 (see all company filings)

EIN.: 832072195 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40215 | Film No.: 23840489
SIC: 2836 Biological Products, (No Diagnostic Substances)